去年 ,美国食品与药物管理局 (ＦＤＡ)建议将去甲麻黄碱 (ｐｈｅｎｙｌｐｒｏｐａｎｏｌａｍｉｎｅ ,通用名为苯丙醇胺 )从非处方药及处方药品目录中撤出来 ,并要求制药公司自动停止生产含有去甲麻黄碱的药物。这一决定是在耶鲁大学完成并公布了一项使用去甲基麻黄碱病人出血性 Last year, the FDA proposed to withdraw phenylpropanolamine (generic name phenylpropanolamine) from the over-the-counter and prescription drugs catalogs and to require that pharmaceutical companies automatically stop producing products containing norephedrine Drug. This decision was completed and announced at Yale University using a hemorrhagic demethylating agent